Global Generic Drugs Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	221 Pages	TechNavio	March, 2025	INF19848633

Best Price Guarantee
Price	from $2,500
Length	221 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19848633

Generic Drugs Market 2025-2029

The generic drugs market is forecasted to grow by USD 217.4 billion during 2024-2029, accelerating at a CAGR of 7.6% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives to branded medicines, increased outsourcing of drug discovery and development, and rising expiry of patents on branded drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generic drugs market is segmented as below:

By Route Of Administration

Oral
Injectables
Topical
Inhalers

By Type

Small-molecule generics
Biosimilars

By Application

Anti-infectives
CNS
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of RPA as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising mergers and acquisitions among companies and emergence of hospital-owned generics will lead to sizable demand in the market.

The report on the generic drugs market covers the following areas:

Generic Drugs Market sizing
Generic Drugs Market forecast
Generic Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Generic Drugs Market 2019 - 2023; Historic Market Size - Data Table on Global Generic Drugs Market 2019 - 2023 ($ billion); 5.2 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion); 5.4 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ billion); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Global Generic Drugs Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Route of Administration: 8.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 8.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 8.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ billion); Data Table on Oral - Market size and forecast 2024-2029 ($ billion); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 8.4 Injectables - Market size and forecast 2024-2029; Chart on Injectables - Market size and forecast 2024-2029 ($ billion); Data Table on Injectables - Market size and forecast 2024-2029 ($ billion); Chart on Injectables - Year-over-year growth 2024-2029 (%); Data Table on Injectables - Year-over-year growth 2024-2029 (%); 8.5 Topical - Market size and forecast 2024-2029; Chart on Topical - Market size and forecast 2024-2029 ($ billion); Data Table on Topical - Market size and forecast 2024-2029 ($ billion); Chart on Topical - Year-over-year growth 2024-2029 (%); Data Table on Topical - Year-over-year growth 2024-2029 (%); 8.6 Inhalers - Market size and forecast 2024-2029; Chart on Inhalers - Market size and forecast 2024-2029 ($ billion); Data Table on Inhalers - Market size and forecast 2024-2029 ($ billion); Chart on Inhalers - Year-over-year growth 2024-2029 (%); Data Table on Inhalers - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ billion); Data Table on Market opportunity by Route of Administration ($ billion)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Small-molecule generics - Market size and forecast 2024-2029; Chart on Small-molecule generics - Market size and forecast 2024-2029 ($ billion); Data Table on Small-molecule generics - Market size and forecast 2024-2029 ($ billion); Chart on Small-molecule generics - Year-over-year growth 2024-2029 (%); Data Table on Small-molecule generics - Year-over-year growth 2024-2029 (%); 9.4 Biosimilars - Market size and forecast 2024-2029; Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion); Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion); Chart on Biosimilars - Year-over-year growth 2024-2029 (%); Data Table on Biosimilars - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Application: 10.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 10.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 10.3 Anti-infectives - Market size and forecast 2024-2029; Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion); Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion); Chart on Anti-infectives - Year-over-year growth 2024-2029 (%); Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%); 10.4 CNS - Market size and forecast 2024-2029; Chart on CNS - Market size and forecast 2024-2029 ($ billion); Data Table on CNS - Market size and forecast 2024-2029 ($ billion); Chart on CNS - Year-over-year growth 2024-2029 (%); Data Table on CNS - Year-over-year growth 2024-2029 (%); 10.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.9 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.10 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.11 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ billion); Data Table on Brazil - Market size and forecast 2024-2029 ($ billion); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 12.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.16 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 15.5 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; SWOT; 15.6 Baxter International Inc.; Baxter International Inc. - Overview; Baxter International Inc. - Business segments; Baxter International Inc. - Key news; Baxter International Inc. - Key offerings; Baxter International Inc. - Segment focus; SWOT; 15.7 Biocon Ltd.; Biocon Ltd. - Overview; Biocon Ltd. - Business segments; Biocon Ltd. - Key offerings; Biocon Ltd. - Segment focus; SWOT; 15.8 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 15.9 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 15.10 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 15.11 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; SWOT; 15.12 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 15.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 15.15 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 15.16 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 15.17 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT; 15.18 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Market Segmentation by Application; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Generic Drugs Market 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Application Segment 2019 - 2023 ($ billion); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits39: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Route of Administration; Exhibits41: Data Table on Comparison by Route of Administration; Exhibits42: Chart on Oral - Market size and forecast 2024-2029 ($ billion); Exhibits43: Data Table on Oral - Market size and forecast 2024-2029 ($ billion); Exhibits44: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Injectables - Market size and forecast 2024-2029 ($ billion); Exhibits47: Data Table on Injectables - Market size and forecast 2024-2029 ($ billion); Exhibits48: Chart on Injectables - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Injectables - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Topical - Market size and forecast 2024-2029 ($ billion); Exhibits51: Data Table on Topical - Market size and forecast 2024-2029 ($ billion); Exhibits52: Chart on Topical - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Topical - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Inhalers - Market size and forecast 2024-2029 ($ billion); Exhibits55: Data Table on Inhalers - Market size and forecast 2024-2029 ($ billion); Exhibits56: Chart on Inhalers - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Inhalers - Year-over-year growth 2024-2029 (%); Exhibits58: Market opportunity by Route of Administration ($ billion); Exhibits59: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits60: Chart on Type - Market share 2024-2029 (%); Exhibits61: Data Table on Type - Market share 2024-2029 (%); Exhibits62: Chart on Comparison by Type; Exhibits63: Data Table on Comparison by Type; Exhibits64: Chart on Small-molecule generics - Market size and forecast 2024-2029 ($ billion); Exhibits65: Data Table on Small-molecule generics - Market size and forecast 2024-2029 ($ billion); Exhibits66: Chart on Small-molecule generics - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Small-molecule generics - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion); Exhibits69: Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion); Exhibits70: Chart on Biosimilars - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Biosimilars - Year-over-year growth 2024-2029 (%); Exhibits72: Market opportunity by Type ($ billion); Exhibits73: Data Table on Market opportunity by Type ($ billion); Exhibits74: Chart on Application - Market share 2024-2029 (%); Exhibits75: Data Table on Application - Market share 2024-2029 (%); Exhibits76: Chart on Comparison by Application; Exhibits77: Data Table on Comparison by Application; Exhibits78: Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion); Exhibits79: Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion); Exhibits80: Chart on Anti-infectives - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on CNS - Market size and forecast 2024-2029 ($ billion); Exhibits83: Data Table on CNS - Market size and forecast 2024-2029 ($ billion); Exhibits84: Chart on CNS - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on CNS - Year-over-year growth 2024-2029 (%); Exhibits86: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits87: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits88: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits90: Market opportunity by Application ($ billion); Exhibits91: Data Table on Market opportunity by Application ($ billion); Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits95: Chart on Geographic comparison; Exhibits96: Data Table on Geographic comparison; Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits130: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits131: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on Brazil - Market size and forecast 2024-2029 ($ billion); Exhibits142: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion); Exhibits143: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ billion); Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits150: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits151: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits152: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits153: Market opportunity By Geographical Landscape ($ billion); Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits155: Impact of drivers and challenges in 2024 and 2029; Exhibits156: Overview on criticality of inputs and factors of differentiation; Exhibits157: Overview on factors of disruption; Exhibits158: Impact of key risks on business; Exhibits159: Companies covered; Exhibits160: Company ranking index; Exhibits161: Matrix on companies position and classification; Exhibits162: Amgen Inc. - Overview; Exhibits163: Amgen Inc. - Product / Service; Exhibits164: Amgen Inc. - Key news; Exhibits165: Amgen Inc. - Key offerings; Exhibits166: SWOT; Exhibits167: Aurobindo Pharma Ltd. - Overview; Exhibits168: Aurobindo Pharma Ltd. - Product / Service; Exhibits169: Aurobindo Pharma Ltd. - Key offerings; Exhibits170: SWOT; Exhibits171: Baxter International Inc. - Overview; Exhibits172: Baxter International Inc. - Business segments; Exhibits173: Baxter International Inc. - Key news; Exhibits174: Baxter International Inc. - Key offerings; Exhibits175: Baxter International Inc. - Segment focus; Exhibits176: SWOT; Exhibits177: Biocon Ltd. - Overview; Exhibits178: Biocon Ltd. - Business segments; Exhibits179: Biocon Ltd. - Key offerings; Exhibits180: Biocon Ltd. - Segment focus; Exhibits181: SWOT; Exhibits182: Cadila Pharmaceuticals Ltd. - Overview; Exhibits183: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits184: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits185: SWOT; Exhibits186: Cipla Inc. - Overview; Exhibits187: Cipla Inc. - Business segments; Exhibits188: Cipla Inc. - Key news; Exhibits189: Cipla Inc. - Key offerings; Exhibits190: Cipla Inc. - Segment focus; Exhibits191: SWOT; Exhibits192: Dr Reddys Laboratories Ltd. - Overview; Exhibits193: Dr Reddys Laboratories Ltd. - Business segments; Exhibits194: Dr Reddys Laboratories Ltd. - Key news; Exhibits195: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits196: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits197: SWOT; Exhibits198: Fresenius SE and Co. KGaA - Overview; Exhibits199: Fresenius SE and Co. KGaA - Business segments; Exhibits200: Fresenius SE and Co. KGaA - Key news; Exhibits201: Fresenius SE and Co. KGaA - Key offerings; Exhibits202: Fresenius SE and Co. KGaA - Segment focus; Exhibits203: SWOT; Exhibits204: Merck and Co. Inc. - Overview; Exhibits205: Merck and Co. Inc. - Business segments; Exhibits206: Merck and Co. Inc. - Key news; Exhibits207: Merck and Co. Inc. - Key offerings; Exhibits208: Merck and Co. Inc. - Segment focus; Exhibits209: SWOT; Exhibits210: Novartis AG - Overview; Exhibits211: Novartis AG - Business segments; Exhibits212: Novartis AG - Key news; Exhibits213: Novartis AG - Key offerings; Exhibits214: Novartis AG - Segment focus; Exhibits215: SWOT; Exhibits216: Pfizer Inc. - Overview; Exhibits217: Pfizer Inc. - Product / Service; Exhibits218: Pfizer Inc. - Key news; Exhibits219: Pfizer Inc. - Key offerings; Exhibits220: SWOT; Exhibits221: Sanofi SA - Overview; Exhibits222: Sanofi SA - Business segments; Exhibits223: Sanofi SA - Key news; Exhibits224: Sanofi SA - Key offerings; Exhibits225: Sanofi SA - Segment focus; Exhibits226: SWOT; Exhibits227: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits228: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits229: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits230: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits231: SWOT